E

ELISABETTA ZANATTA

Last name: ELISABETTA ZANATTA

2023 (v1)

Publication

Metadata-only

Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS)

MARGHERITA ZEN MARIELE GATTO Roberto Depascale

Aim: To assess the efficacy of belimumab in joint and skin manifestations in a nationwide cohort of patients with SLE. Methods: All patients with skin and joint involvement enrolled in the BeRLiSS cohort were considered. Belimumab (intravenous, 10 mg/kg) effectiveness in joint and skin manifestations was assessed by DAS28 and CLASI,...

Uploaded on: February 7, 2024
2023 (v1)

Publication

Metadata-only

Does the impact of COVID-19 on patients with systemic sclerosis change over time?

Elisabeth Deibel Patricia E. Carreira Madelon Vonk

Objective:Outcome of COVID-19 patients improved over the pandemic, i ncludi ngpatients with systemic rheumatic diseases. However, data on systemic sclerosis (SSc)patients are lacking. Th is study aimed to assess the outcome of SSc patients withCOV ID-19 over several waves. Methods:SSc patients with COVID-19 registered in...

Uploaded on: February 13, 2024